Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
MethodsX ; 8: 101312, 2021.
Article in English | MEDLINE | ID: mdl-34434832

ABSTRACT

Iron nanoparticles are used as a targeted drug delivery system. The nanocarrier itself can be genotoxic, trigger oxidative stress or cell death. Therefore, we developed an AC/DC magnetic syringe for injecting, stimulating drug release and safe removing of the nanocarrier. Alongside we optimized the method for nanoparticles' drug release kinetics and testing cytotoxicity in vitro.•This paper presents detailed instructions for construction of AC/DC magnetic syringe device for stimulated drug release, injection and ejection of magnetic nanoparticles; nanoparticles preparation; adsorbing methylene blue on nanoparticles; determination of drug release kinetics from nanocarriers on the example of methylene blue•Gomori´s Prussian blue reaction for differentiated SH-SY5Y human neuroblastoma cell line; MTT viability assay optimized for differentiated SH-SY5Y human neuroblastoma cell line and antioxidant enzymes activities assay and lipid peroxidation methods are optimized for cell analyses cell cultivation for nanoparticles cytotoxicity testing in vitro.•Those protocols are the first step toward further testing the effect of nanoparticles in vivo, on brain tissue.

2.
J Hazard Mater ; 409: 124918, 2021 05 05.
Article in English | MEDLINE | ID: mdl-33422751

ABSTRACT

Continuing our previous research work on a drug delivery system based on combined AC/DC magnetic fields, we have developed a prototype AC/DC magnetic syringe device for stimulation of drug release from drug carriers, with the options of injecting/removing drug carriers. The porous Fe3O4 carrier, in a dose-dependent manner, causes acute oxidative damage and reduces the viability of differentiated SH-SY5Y human neuroblastoma cells, indicating the necessity for its removal once it reaches the therapeutic concentration at the target tissue. The working mechanism of the device consists of three simple steps. First, direct injection of the drug adsorbed on the surface of a carrier via a needle inserted into the targeted area. The second step is stimulation of drug release using a combination of AC magnetic field (a coil magnetised needle with AC current) and permanent magnets (DC magnetic lens outside of the body), and the third step is removal of the drug carriers from the injected area after the completion of drug release by magnetising the tip of the needle with DC current. Removing the drug carriers allows us to avoid possible acute and long term side effects of the drug carriers in the patient's body, as well as any potential response of the body to the drug carriers.


Subject(s)
Drug Carriers , Magnets , Drug Liberation , Humans , Magnetic Fields , Magnetics
3.
J Hazard Mater ; 394: 122571, 2020 07 15.
Article in English | MEDLINE | ID: mdl-32229386

ABSTRACT

In this study, cellulose nanofibers are used as a template to synthesise magnetic nanoparticles with a uniform size distribution. Magnetic nanoparticles are grafted on the surface of nanofibers via in situ hydrolysis of metal precursors at room temperature. Effects of different concentrations of nanofibers on the morphology, the crystallite size of magnetic nanoparticles, and the thermal and magnetic properties of the membrane produced from the cellulose nanofibers decorated with magnetic nanoparticles are examined. The sizes of magnetic nanoparticles produced in this study are below 20 nm, and the crystallite size of the nanoparticles is in the range of 96-130 Å. The flexible magnetic membranes containing a high concentration of magnetic nanoparticles (83-60 wt%) showed superparamagnetic behaviour with very high magnetic properties (67.4-38.5 emu g-1). The magnetic membrane was then used as an environmentally friendly, low-cost catalyst in a sulphate radical-based advanced oxidation process. The membranes successfully activated peroxymonosulphate (PMS) to remove Rhodamine B (RhB), a common hydrophilic organic dye applied in industry. 94.9 % of the Rhodamine B was degraded in 300 min at room temperature, indicating that the magnetic nanocellulose membrane is highly effective for catalyzing PMS to remove RhB.

4.
Article in English | MEDLINE | ID: mdl-27690076

ABSTRACT

Mobile phone subscriptions continue to increase across the world, with the electromagnetic fields (EMF) emitted by these devices, as well as by related technologies such as Wi-Fi and smart meters, now ubiquitous. This increase in use and consequent exposure to mobile communication (MC)-related EMF has led to concern about possible health effects that could arise from this exposure. Although much research has been conducted since the introduction of these technologies, uncertainty about the impact on health remains. The Australian Centre for Electromagnetic Bioeffects Research (ACEBR) is a National Health and Medical Research Council Centre of Research Excellence that is undertaking research addressing the most important aspects of the MC-EMF health debate, with a strong focus on mechanisms, neurodegenerative diseases, cancer, and exposure dosimetry. This research takes as its starting point the current scientific status quo, but also addresses the adequacy of the evidence for the status quo. Risk communication research complements the above, and aims to ensure that whatever is found, it is communicated effectively and appropriately. This paper provides a summary of this ACEBR research (both completed and ongoing), and discusses the rationale for conducting it in light of the prevailing science.

5.
Eur Biophys J ; 44(8): 647-54, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26184724

ABSTRACT

Liposomal drug delivery systems (LDDSs) are promising tools used for the treatment of diseases where highly toxic pharmacological agents are administered. Currently, destabilising LDDSs by a specific stimulus at a target site remains a major challenge. The bacterial mechanosensitive channel of large conductance (MscL) presents an excellent candidate biomolecule that could be employed as a remotely controlled pore-forming nanovalve for triggered drug release from LDDSs. In this study, we developed superparamagnetic nanoparticles for activation of the MscL nanovalves by magnetic field. Synthesised CoFe2O4 nanoparticles with the radius less than 10 nm were labelled by SH groups for attachment to MscL. Activation of MscL by magnetic field with the nanoparticles attached was examined by the patch clamp technique showing that the number of activated channels under ramp pressure increased upon application of the magnetic field. In addition, we have not observed any cytotoxicity of the nanoparticles in human cultured cells. Our study suggests the possibility of using magnetic nanoparticles as a specific trigger for activation of MscL nanovalves for drug release in LDDSs.


Subject(s)
Escherichia coli Proteins/chemistry , Ion Channels/chemistry , Liposomes/chemistry , Magnetite Nanoparticles/chemistry , Cell Line, Tumor , Cobalt/chemistry , Ferric Compounds/chemistry , Humans , Magnetic Fields , Magnetite Nanoparticles/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...